NEW YORK, June 14, Jun 14, 2022 (GLOBE NEWSWIRE via COMTEX) --
NEW YORK, June 14, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Turning Point Therapeutics, Inc. /zigman2/quotes/211319679/composite TPTX 0.00% 's sale to Bristol Myers Squibb for $76.00 per share. If you are a Turning Point shareholder, click here to learn more about your rights and options .
ManTech International Corporation /zigman2/quotes/207993719/composite MANT +0.05% 's sale to Carlyle Group Inc. for $96.00 per share in cash. If you are a ManTech shareholder, click here to learn more about your rights and options .
Centennial Resource Development, Inc. /zigman2/quotes/207935988/composite CDEV +3.77% 's merger with Colgate Energy Partners III, LLC. If you are a Centennial shareholder, click here to learn more about your rights and options .
CatchMark Timber Trust, Inc. /zigman2/quotes/202675836/composite CTT +1.95% 's sale to PotlatchDeltic Corporation for 0.23 common shares of PotlatchDeltic stock for each common share of CatchMark. If you are a CatchMark shareholder, click here to learn more about your rights and options .
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email email@example.com or firstname.lastname@example.org .
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.
(C) Copyright 2022 GlobeNewswire, Inc. All rights reserved.